circRNA basic information
circBase ID: hsa_circ_0048856
Name: hsa_circ_C3
Synonym: circ_0048856
Host Gene: C3
Genomic location(hg19): chr19:6677845-6680274:-
Genomic location(hg38): chr19:6677834-6680263:-
Subcellular localization: cytoplasm
 
 
 
 
 
 
 
Disease basic information
MONDO ID:
0008903
MONDO name: lung cancer
Disease details: lung cancer
Disease DO ID:
1324
Disease MeSH ID:
-
Disease NCIt ID:
C7377
Disease ICD11 ID:
-
Disease OMIM ID:
211980
Species: Human
Species details: Homo sapiens
Tissue specimen:

lung cancer tissues; matched noncancer tissues; DDP-sensitive lung cancer tissues; DDP-resistant lung cancer tissues; xenograft tumor tissues

Cell lines:

H1650; A549; H1299; HBE; A549/DDP; H1299/DDP

In vivo animal model:

cell line-derived xenograft

circRNA-disease information
Expression pattern:
UP
Associated gene: ABCC1, Ago2, MDR1, Cleaved-caspase-3
Associated microRNA: miR-193a-5p, miR-98-5p
Biological function: circ_0048856 promotes DDP resistance, tumor growth, proliferation and invasion, and suppresses apoptosis in lung cancer cells; circ_0048856 knockdown re-sensitizes DDP-resistant lung cancer cells to DDP and suppresses tumorigenesis in vitro and in vivo.
Molecular mechanism: circ_0048856 acts as a ceRNA/miRNA sponge for miR-193a-5p and miR-98-5p to regulate ABCC1, thereby promoting DDP resistance and tumorigenesis in lung cancer.
Biological pathway or process:

ceRNA regulation (promotes); drug resistance (promotes); chemoresistance (promotes); proliferation (promotes); invasion (promotes); apoptosis (inhibits)

Detected method:
Q
Validation methods:

RNase R Treatment; RT-qPCR; Nuclear-Cytoplasmic Fractionation; Clinical Sample Validation; RIP (RNA Immunoprecipitation); Luciferase Reporter Assay; Transfection; CCK8; EdU Staining; Annexin V/PI Flow Cytometry; Transwell Assay; In Vivo Animal Model; IHC (Immunohistochemistry); Western Blot; Bioinformatics Analysis

Clinical significance:

circ_0048856 is highly expressed in DDP-resistant lung cancer tissues and may be a therapeutic target for improving cisplatin treatment efficacy.

Description:

circ_0048856 is up-regulated in DDP-resistant lung cancer tissues and cells. It promotes cisplatin resistance, proliferation, invasion and tumor growth while inhibiting apoptosis, mainly by sponging miR-193a-5p and miR-98-5p to regulate ABCC1. Knockdown of circ_0048856 restores DDP sensitivity and suppresses tumorigenesis in vitro and in a xenograft model.

Confidence score:

0.8174

Other information
Title:

Circ_0048856 competes with ABCC1 for miR-193a-5p/miR-98-5p binding sites to promote the cisplatin resistance and tumorigenesis in lung cancer.

Journal: Journal of chemotherapy (Florence, Italy)
Published: 2023
PubMed ID: 35289739
Study type:

combined biological and clinical study

Data availability: -
Code availability: -